Enzyme kinetics of cellulose hydrolysis of Miscanthus and oat hulls

Autor Makarova, Ekaterina I., Budaeva, Vera V., Kukhlenko, Aleksey A., Orlov, Sergey E.
Vydáno v 3 Biotech (2017)

Rapid Improvement of the Performance Status and Reduction of the Tumor Size in KRAS-Mutated Colorectal Cancer Patient Receiving Binimetinib, Hydroxychloroquine, and Bevacizumab

Autor Orlov, Sergey V., Urtenova, Magaripa A., Sviridenko, Maria A., Nesterov, Denis V., Sokolova, Tatiana N., Imyanitov, Evgeny N.
Vydáno v Case Rep Oncol (2020)

Peroxisome Proliferator-activated Receptor α Positively Regulates Complement C3 Expression but Inhibits Tumor Necrosis Factor α-mediated Activation of C3 Gene in Mammalian Hepatic-...

Autor Mogilenko, Denis A., Kudriavtsev, Igor V., Shavva, Vladimir S., Dizhe, Ella B., Vilenskaya, Ekaterina G., Efremov, Alexander M., Perevozchikov, Andrej P., Orlov, Sergey V.
Vydáno 2013

FOXO1 and LXRα downregulate the apolipoprotein A-I gene expression during hydrogen peroxide-induced oxidative stress in HepG2 cells

Autor Shavva, Vladimir S., Bogomolova, Alexandra M., Nikitin, Artemy A., Dizhe, Ella B., Oleinikova, Galina N., Lapikov, Ivan A., Tanyanskiy, Dmitry A., Perevozchikov, Andrej P., Orlov, Sergey V.
Vydáno v Cell Stress Chaperones (2016)

Modified Low Density Lipoprotein Stimulates Complement C3 Expression and Secretion via Liver X Receptor and Toll-like Receptor 4 Activation in Human Macrophages

Autor Mogilenko, Denis A., Kudriavtsev, Igor V., Trulioff, Andrey S., Shavva, Vladimir S., Dizhe, Ella B., Missyul, Boris V., Zhakhov, Alexander V., Ischenko, Alexander M., Perevozchikov, Andrej P., Orlov, Sergey V.
Vydáno 2012

Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients wit...

Autor Buttigliero, Consuelo, Shepherd, Frances A., Barlesi, Fabrice, Schwartz, Brian, Orlov, Sergey, Favaretto, Adolfo G., Santoro, Armando, Hirsh, Vera, Ramlau, Rodryg, Blackler, Adele R., Roder, Joanna, Spigel, David, Novello, Silvia, Akerley, Wallace, Scagliotti, Giorgio V.
Vydáno v Oncologist (2018)

Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study

Autor Gambacorti‐Passerini, Carlo, Orlov, Sergey, Zhang, Li, Braiteh, Fadi, Huang, Huiqiang, Esaki, Taito, Horibe, Keizo, Ahn, Jin‐Seok, Beck, Joseph T., Edenfield, William Jeffrey, Shi, Yuankai, Taylor, Matthew, Tamura, Kenji, Van Tine, Brian A., Wu, Shang‐Ju, Paolini, Jolanda, Selaru, Paulina, Kim, Tae Min
Vydáno v Am J Hematol (2018)

Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non–Small Cell Lung Cancer: The SELECT-1 Randomized Cli...

Autor Jänne, Pasi A., van den Heuvel, Michel M., Barlesi, Fabrice, Cobo, Manuel, Mazieres, Julien, Crinò, Lucio, Orlov, Sergey, Blackhall, Fiona, Wolf, Juergen, Garrido, Pilar, Poltoratskiy, Artem, Mariani, Gabriella, Ghiorghiu, Dana, Kilgour, Elaine, Smith, Paul, Kohlmann, Alexander, Carlile, David J., Lawrence, David, Bowen, Karin, Vansteenkiste, Johan
Vydáno v JAMA (2017)

Efficacy of lorlatinib in lung carcinomas carrying distinct ALK translocation variants: The results of a single-center study

Autor Orlov, Sergey V., Iyevleva, Aglaya G., Filippova, Elena A., Lozhkina, Alexandra M., Odintsova, Svetlana V., Sokolova, Tatiana N., Mitiushkina, Natalia V., Tiurin, Vladislav I., Preobrazhenskaya, Elena V., Romanko, Alexandr A., Martianov, Alexandr S., Ivantsov, Alexandr O., Aleksakhina, Svetlana N., Togo, Alexandr V., Imyanitov, Evgeny N.
Vydáno v Transl Oncol (2021)

CMET-22. CAPMATINIB (INC280) IN METΔEX14-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): EFFICACY DATA FROM THE PHASE 2 GEOMETRY MONO-1 STUDY

Autor Heist, Rebecca S, Seto, Takashi, Han, Ji-Youn, Reguart, Noemi, Garon, Edward B, Groen, Harry J M, Tan, Daniel S W, Hida, Toyoaki, de Jonge, Maja, V Orlov, Sergey, Smit, Egbert F, Souquet, Pierre-Jean, Vansteenkiste, Johan, Le Mouhaer, Sylvie, Robeva, Anna, Waldron-Lynch, Maeve, Giovannini, Monica, Wolf, Juergen
Vydáno v Neuro Oncol (2019)

Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates

Autor Baklaushev, Vladimir P, Durov, Oleg V, Kalsin, Vladimir A, Gulaev, Eugene V, Kim, Sergey V, Gubskiy, Ilya L, Revkova, Veronika A, Samoilova, Ekaterina M, Melnikov, Pavel A, Karal-Ogly, Dzhina D, Orlov, Sergey V, Troitskiy, Alexander V, Chekhonin, Vladimir P, Averyanov, Alexander V, Ahlfors, Jan-Eric
Vydáno v World J Stem Cells (2021)

Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung c...

Autor Garon, Edward B, Scagliotti, Giorgio Vittorio, Gautschi, Oliver, Reck, Martin, Thomas, Michael, Iglesias Docampo, Lara, Kalofonos, Haralabos, Kim, Joo-Hang, Gans, Steven, Brustugun, Odd Terje, Orlov, Sergey V, Cuyun Carter, Gebra, Zimmermann, Annamaria H, Oton, Ana B, Alexandris, Ekaterine, Lee, Pablo, Wolff, Katharina, Stefaniak, Victoria Jennifer, Socinski, Mark A, Pérol, Maurice
Vydáno v ESMO Open (2020)

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

Autor Spigel, David R., Ervin, Thomas J., Ramlau, Rodryg A., Daniel, Davey B., Goldschmidt, Jerome H., Blumenschein, George R., Krzakowski, Maciej J., Robinet, Gilles, Godbert, Benoit, Barlesi, Fabrice, Govindan, Ramaswamy, Patel, Taral, Orlov, Sergey V., Wertheim, Michael S., Yu, Wei, Zha, Jiping, Yauch, Robert L., Patel, Premal H., Phan, See-Chun, Peterson, Amy C.
Vydáno v J Clin Oncol (2013)

A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma

Autor van Brummelen, Emilie M. J., Levchenko, Evgeny, Dómine, Manuel, Fennell, Dean A., Kindler, Hedy L., Viteri, Santiago, Gadgeel, Shirish, López, Pilar Garrido, Kostorov, Vladimir, Morgensztern, Daniel, Orlov, Sergey, Zauderer, Marjorie G., Vansteenkiste, Johan F., Baker-Neblett, Katherine, Vasquez, James, Wang, Xiaowei, Bellovin, David I., Schellens, Jan H. M., Yan, Li, Mitrica, Ionel, DeYoung, M. Phillip, Trigo, José
Vydáno v Invest New Drugs (2019)